I’ve been directing or advising innovation and commercialization efforts in Silicon Valley for most of my career. While the popular stories we tell about innovation usually focus on eureka moments and brilliant individuals, anyone involved in successful innovation knows that getting a new product to market is often more about convincing smart people to back your idea, corralling lots of different agendas, aligning incentives, and navigating bureaucracies.
I was reminded of this very important difference between invention and impactful innovation when I attended the One Mind for Research conference at UCLA recently. One Mind for Research is a new nonprofit that serves as a catalyst for discovering and delivering breakthrough cures for brain disease, co-founded by Garen Steglin, a successful VC and CEO, and Patrick Kennedy, former Congressman and nephew of JFK, and now led by Pete Chiarelli, U.S. Army General (retired).This was a gathering of top university neuroscientists, celebrities like Glenn Close and Maria Shriver, foundations, industry senior executives, government officials, patients, and advocates.
To read the full, original article click on this link: Medical Innovation Needs Silicon Valley Speed, Stat | Fast Company
